Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Buy
4,966
+3,776
+317% +$1.29M 0.41% 49
2026
Q1
$419K Sell
1,190
-916
-43% -$327K 0.14% 129
2025
Q4
$689K Buy
2,106
+1,015
+93% +$322K 0.18% 105
2025
Q3
$308K Buy
1,091
+2
+0.2% +$580 0.09% 141
2025
Q2
$304K Buy
1,089
+13
+1% +$3.68K 0.11% 131
2025
Q1
$335K Buy
1,076
+40
+4% +$11.8K 0.15% 112
2024
Q4
$270K Sell
1,036
-64
-6% -$19K 0.18% 128
2024
Q3
$354K Buy
1,100
+23
+2% +$7.52K 0.2% 104
2024
Q2
$337K Buy
1,077
+31
+3% +$9.11K 0.17% 110
2024
Q1
$297K Sell
1,046
-96
-8% -$28.1K 0.19% 112
2023
Q4
$329K Buy
1,142
+192
+20% +$52.3K 0.23% 99
2023
Q3
$255K Buy
+950
New +$237K 0.21% 107

Other funds holding AMGN

New Republic Capital's AMGN Position: Q2 2026 in Review

New Republic Capital increased its Amgen (AMGN) stake by 317% in Q2 2026, buying an estimated $1.29M and bringing the position to 4,966 shares worth $1.8M. The position accounts for 0.41% of the portfolio, ranked #49.

New Republic Capital first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • New Republic Capital held 4,966 shares of Amgen worth $1.8M as of Q2 2026.
  • New Republic Capital bought 3,776 Amgen shares in Q2 2026, an estimated $1.29M.
  • Amgen made up 0.41% of New Republic Capital's portfolio in Q2 2026, its #49 holding.
  • New Republic Capital first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.